Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% and closed at $0.0959 in last trading session. The biotech firm is still in clinical stage and it is working to develop targeted therapies to treat diabetes and cancer based on Cell-in-a-Box® technology. Recently, the COO of Pharmacyte, Dr. Gerald W. Crabtree, Ph.D. highlighted company’s development plans in an […]
Shire PLC (ADR)
Medtronic, Inc. (NYSE:MDT) To Reimburse Top Executives, Directors For Inversion Taxes Bills
Boston, MA 09/02/2014 (wallstreetpr) – Medtronic, Inc. (NYSE:MDT) will compensate its top executives and directors for the tax imposed on their stock and option awards in relation to the inversion efforts that the company is undertaking, Wall Street Journal stated in an article. The company seeks to shift its corporate office from the U.S. through […]